SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-15-000124
Filing Date
2015-08-14
Accepted
2015-08-14 16:27:39
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 494908
2 exhibit31-1.htm EX-31.1 14071
3 exhibit32-1.htm EX-32.1 7298
4 exhibit10-1.htm EX-10.1 154790
  Complete submission text file 0001424884-15-000124.txt   2176843

Data Files

Seq Description Document Type Size
5 tpiv-20150630.xml EX-101.INS 248732
6 tpiv-20150630.xsd EX-101.SCH 26071
7 tpiv-20150630_cal.xml EX-101.CAL 30445
8 tpiv-20150630_def.xml EX-101.DEF 79418
9 tpiv-20150630_lab.xml EX-101.LAB 180816
10 tpiv-20150630_pre.xml EX-101.PRE 143636
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 151056269
SIC: 2834 Pharmaceutical Preparations